Ocular Therapeutix (OCUL) Enterprise Value (2014 - 2026)
Ocular Therapeutix's Enterprise Value was $1.56 billion in Q2 2026, up 28.4% from $1.21 billion a year earlier and up 31.2% from the prior quarter.
Ocular Therapeutix (OCUL) Enterprise Value (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ocular Therapeutix's Enterprise Value was -$190.81 million through Jun 30, 2026; for FY2025, it came in at $1.88 billion, up 97.3% from FY2024.
- Enterprise Value has now increased for three consecutive years, with a five-year compound annual growth rate of 12.9% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $955.08 million in FY2024 (+496.1%), $160.22 million in FY2023 (+39.8%), $114.64 million in FY2022 (-69.1%) and $370.66 million in FY2021 (-64.0%).
- Quarterly Enterprise Value has moved between $114.64 million (Q4 2022) and $1.88 billion (Q4 2025) over five years.
- Compared with a year earlier, Enterprise Value has increased for five straight quarters, with growth averaging 176.5% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q3 2024 (growth of 574.1%); the worst was Q2 2022 (a decline of 80.4%).
- Per Business Quant data, OCUL's Enterprise Value in the three quarters before Q2 2026 was $1.19 billion (Q1 2026), $1.88 billion (Q4 2025) and $1.7 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.56 Bn |
| Mar 31, 2026 | 1.19 Bn |
| Dec 31, 2025 | 1.88 Bn |
| Sep 30, 2025 | 1.70 Bn |
| Jun 30, 2025 | 1.21 Bn |
| Mar 31, 2025 | 817.71 Mn |
| Dec 31, 2024 | 955.08 Mn |
| Sep 30, 2024 | 935.68 Mn |
| Jun 30, 2024 | 604.78 Mn |
| Mar 31, 2024 | 924.92 Mn |
| Dec 31, 2023 | 160.22 Mn |
| Sep 30, 2023 | 138.80 Mn |
| Jun 30, 2023 | 342.24 Mn |
| Mar 31, 2023 | 329.49 Mn |
| Dec 31, 2022 | 114.64 Mn |
| Sep 30, 2022 | 198.64 Mn |
| Jun 30, 2022 | 174.64 Mn |
| Mar 31, 2022 | 234.54 Mn |
| Dec 31, 2021 | 370.66 Mn |
| Sep 30, 2021 | 586.79 Mn |
Ocular Therapeutix Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=OCUL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();